Literature DB >> 1798887

Subjective sleepiness ratings: the effects of sleep deprivation, circadian rhythmicity and cognitive performance.

H Babkoff1, T Caspy, M Mikulincer.   

Abstract

Computerized self-report sleepiness scales were administered before and after cognitive testing in a 72-hour sleep deprivation study. The cognitive test battery was administered every 2 hours and took approximately 1-1.25 hours. Two computerized measures of subjective sleepiness were used, one a visual analog scale, the other a Hebrew version of the Stanford sleepiness scale. The results indicated that both accumulated sleep loss, circadian and ultradian (2 cycles/day) factors were significant in determining subjective estimates of sleepiness. The extent of the differences between subjective sleepiness ratings before cognitive testing and after testing was dependent upon the phase of the circadian cycle. These differences were greatest at approximately 0200-0600 hours and least around 1000 hours. A second low point occurred at 1800-2000 hours. Analysis by complex demodulation of the individual subjects' sleepiness rating curves indicated that the amount of variance accounted for by the circadian component increased significantly after cognitive testing.

Entities:  

Mesh:

Year:  1991        PMID: 1798887     DOI: 10.1093/sleep/14.6.534

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  17 in total

1.  What is the best measure of daytime sleepiness in adults with heart failure?

Authors:  Barbara Riegel; Alexandra L Hanlon; Xuemei Zhang; Desiree Fleck; Steven L Sayers; Lee R Goldberg; William S Weintraub
Journal:  J Am Assoc Nurse Pract       Date:  2012-09-24       Impact factor: 1.165

2.  A specific role for the thalamus in mediating the interaction of attention and arousal in humans.

Authors:  C M Portas; G Rees; A M Howseman; O Josephs; R Turner; C D Frith
Journal:  J Neurosci       Date:  1998-11-01       Impact factor: 6.167

3.  Improved neurobehavioral performance during the wake maintenance zone.

Authors:  Julia A Shekleton; Shantha M W Rajaratnam; Joshua J Gooley; Eliza Van Reen; Charles A Czeisler; Steven W Lockley
Journal:  J Clin Sleep Med       Date:  2013-04-15       Impact factor: 4.062

4.  Heart rate variability can be used to estimate sleepiness-related decrements in psychomotor vigilance during total sleep deprivation.

Authors:  Eric Chern-Pin Chua; Wen-Qi Tan; Sing-Chen Yeo; Pauline Lau; Ivan Lee; Ivan Ho Mien; Kathiravelu Puvanendran; Joshua J Gooley
Journal:  Sleep       Date:  2012-03-01       Impact factor: 5.849

Review 5.  Sleep disorders in school-age children.

Authors:  S Kotagal
Journal:  Indian J Pediatr       Date:  1997 Sep-Oct       Impact factor: 1.967

6.  Sustained attention performance during sleep deprivation associates with instability in behavior and physiologic measures at baseline.

Authors:  Eric Chern-Pin Chua; Sing-Chen Yeo; Ivan Tian-Guang Lee; Luuan-Chin Tan; Pauline Lau; Shiwei Cai; Xiaodong Zhang; Kathiravelu Puvanendran; Joshua J Gooley
Journal:  Sleep       Date:  2014-01-01       Impact factor: 5.849

7.  Sleep deprivation in adolescents and adults: changes in affect.

Authors:  Lisa S Talbot; Eleanor L McGlinchey; Katherine A Kaplan; Ronald E Dahl; Allison G Harvey
Journal:  Emotion       Date:  2010-12

8.  The cardiovascular and central nervous system effects in the human of U-62066E. A selective opioid receptor agonist.

Authors:  G H Rimoy; D M Wright; N K Bhaskar; P C Rubin
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

9.  Determinants of Behavioral Alertness in Adults with Heart Failure.

Authors:  Ruth Masterson Creber; Victoria M Pak; Miranda Varrasse; David F Dinges; Joyce Wald; Barbara Riegel
Journal:  J Clin Sleep Med       Date:  2016-04-15       Impact factor: 4.062

10.  A systematic review of sleep deprivation and neurobehavioral function in young adults.

Authors:  Stephanie Griggs; Alison Harper; Ronald L Hickman
Journal:  Appl Nurs Res       Date:  2021-12-12       Impact factor: 2.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.